Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

ITCI

Intra Cellular Therapies (ITCI)

Intra Cellular Therapies Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ITCI
일자시간출처헤드라인심볼기업
2024/05/2921:00GlobeNewswire Inc.Intra-Cellular Therapies to Present at the Jefferies Global Healthcare ConferenceNASDAQ:ITCIIntra Cellular Therapies Inc
2024/05/2321:00GlobeNewswire Inc.Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual MeetingNASDAQ:ITCIIntra Cellular Therapies Inc
2024/05/0821:00GlobeNewswire Inc.Intra-Cellular Therapies to Participate in Two Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/05/0720:43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITCIIntra Cellular Therapies Inc
2024/05/0720:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
2024/05/0720:30GlobeNewswire Inc.Intra-Cellular Therapies Reports First Quarter 2024 Financial ResultsNASDAQ:ITCIIntra Cellular Therapies Inc
2024/04/3021:00GlobeNewswire Inc.Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and WebcastNASDAQ:ITCIIntra Cellular Therapies Inc
2024/04/2505:01GlobeNewswire Inc.Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/04/1809:46GlobeNewswire Inc.Intra-Cellular Therapies Prices Public Offering of Common StockNASDAQ:ITCIIntra Cellular Therapies Inc
2024/04/1705:06GlobeNewswire Inc.Intra-Cellular Therapies Announces Proposed Public Offering of Common StockNASDAQ:ITCIIntra Cellular Therapies Inc
2024/04/1620:00GlobeNewswire Inc.Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive DisorderNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/1921:30GlobeNewswire Inc.Intra-Cellular Therapies Announces Executive Appointments and Leadership ChangesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/1205:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/1205:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/1205:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0907:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0907:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0907:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0907:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0806:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0806:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0806:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0806:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0622:00GlobeNewswire Inc.Intra-Cellular Therapies to Participate in Three Upcoming Investor ConferencesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0609:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0609:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0609:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/03/0609:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/02/2810:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
2024/02/2809:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITCIIntra Cellular Therapies Inc
 검색 관련기사 보기:NASDAQ:ITCI